Laurus Labs Limited — Investor Relations & Filings
Laurus Labs Limited is a research-driven organization focused on the development and manufacturing of active pharmaceutical ingredients (APIs), finished dosage forms (FDF), and specialized synthesis services. The company operates across several key therapeutic areas, including anti-retroviral (ARV), oncology, cardiovascular, and anti-diabetic treatments. Through its contract development and manufacturing organization (CDMO) division, it provides integrated drug development solutions to global partners. The company also maintains a biotechnology segment dedicated to recombinant products. Leveraging advanced research and development capabilities alongside large-scale manufacturing infrastructure, the firm emphasizes process chemistry innovation and cost-efficient production to serve diverse global healthcare markets.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Updates | 2017-08-18 | English | |
| Press Release | 2017-08-10 | English | |
| Investor Presentation | 2017-08-10 | English | |
| Financial Results Updates | 2017-08-10 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2017-08-03 | English | |
| Board Meeting — Results | 2017-08-01 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2017
15 filings
| |||||
| 43635231 | Updates | 2017-08-18 | English | ||
| 43615809 | Press Release | 2017-08-10 | English | ||
| 43615861 | Investor Presentation | 2017-08-10 | English | ||
| 43616069 | Financial Results Updates | 2017-08-10 | English | ||
| 43620626 | Analysts/Institutional Investor Meet/Con. Call Updates | 2017-08-03 | English | ||
| 44061601 | Board Meeting — Results | 2017-08-01 | English | ||
| 43641411 | Shareholders meeting | 2017-07-14 | English | ||
| 43641430 | Shareholders meeting | 2017-07-14 | English | ||
| 43633961 | Press Release | 2017-07-05 | English | ||
| 43635515 | Credit Rating | 2017-07-04 | English | ||
| 43639773 | Analysts/Institutional Investor Meet/Con. Call Updates | 2017-05-31 | English | ||
| 43672443 | Updates | 2017-05-19 | English | ||
| 43639208 | Press Release | 2017-05-18 | English | ||
| 43639302 | AGM/Book Closure | 2017-05-18 | English | ||
| 43639320 | Outcome of Board Meeting | 2017-05-18 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Laurus Labs Limited via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/62639/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=62639 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=62639 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=62639 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 62639}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Laurus Labs Limited (id: 62639)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.